| Literature DB >> 35562242 |
Suzanne W Boyer1, Christin Johnsen1, Eva Morava2.
Abstract
Congenital disorders of glycosylation (CDG) are a group of more than 160 inborn errors of metabolism affecting multiple pathways of protein and lipid glycosylation. Patients present with a wide range of symptoms and therapies are only available for very few subtypes. Specific nutritional treatment options for certain CDG types include oral supplementation of monosaccharide sugars, manganese, uridine, or pyridoxine. Additional management includes specific diets (i.e., complex carbohydrate or ketogenic diet), iron supplementation, and albumin infusions. We review the dietary management in CDG with a focus on two subgroups: N-linked glycosylation defects and GPI-anchor disorders.Entities:
Keywords: GPI-anchor disorder; N-linked CDG; hypoglycemia; manganese; monosaccharide therapy; pyridoxine
Mesh:
Year: 2022 PMID: 35562242 PMCID: PMC9375550 DOI: 10.1016/j.molmed.2022.04.003
Source DB: PubMed Journal: Trends Mol Med ISSN: 1471-4914 Impact factor: 15.272